Skip to content

Kala Azar Susceptibility 3 C1969648

Published: July 22, 2026Updated: August 20, 2026

A genetic factor that may increase susceptibility to visceral leishmaniasis, a parasitic disease affecting internal organs. Individuals with this susceptibility have a potentially higher risk of infection when exposed to the parasite.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
R69
ICD-11
MA00.0
Body system
immunologic
Severity
mild
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fever

(immunologic)

Generalized symptoms

(immunologic)

Mild symptoms that may not significantly impact daily life.

Frequency: Varies

Weight loss

(immunologic)

Hepatosplenomegaly

(immunologic)

Pancytopenia

(immunologic)

Medication Comparisons

Compare medications used to treat Kala Azar Susceptibility 3 C1969648. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy